| [13] |
王悦至，陈强. 炎症性肠病的肾脏损害[J]. 国际泌尿系统杂志，2021, 41(2): 354-356.
|
| [14] |
Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease [J]. Clin J Am Soc Nephrol, 2014, 9(2): 265-270.
|
| [15] |
Takemura T, Okada M, Yagi K, et al. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications [J]. Pediatr Nephrol, 2002, 17(10): 863-866.
|
| [16] |
Saha MK, Julian BA, Novak J, et al. Secondary IgA nephropathy [J]. Kidney Int, 2018, 94(4): 674-681.
|
| [17] |
Kiryluk K, Li Y, Scolari F, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens [J]. Nat Genet, 2014, 46(11): 1187-1196.
|
| [18] |
Lewis B, Mukewar S, Lopez R, et al. Frequency and risk factors of renal insufficiency in inflammatory bowel disease inpatients [J]. Inflamm Bowel Dis, 2013, 19(9): 1846-1851.
|
| [19] |
Primas C, Novacek G, Schweiger K, et al. Renal insufficiency in IBD-prevalence and possible pathogenetic aspects [J]. J Crohns Colitis, 2013, 7(12): e630-e634.
|
| [20] |
Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, et al. Amyloidosis in inflammatory bowel disease: a systematic review of epidemiology, clinical features, and treatment [J]. J Crohns Colitis, 2016, 10(10): 1245-1253.
|
| [1] |
郑连鹏，吕宗舜，张洁，等. 中国大陆地区炎症性肠病肠外表现的汇总分析[J]. 世界华人消化杂志，2009, 17(21) : 2217-2220.
|
| [2] |
Mendoza JL, Lana R, Taxonera C, et al. Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn′s disease and ulcerative colitis [J]. Med Clin (Barc), 2005, 125(8): 297-300.
|
| [3] |
Ambruzs JM, Larsen CP. Renal manifestations of inflammatory bowel disease [J]. Rheum Dis Clin North Am, 2018, 44(4): 699-714.
|
| [4] |
Corica D, Romano C. Renal involvement in inflammatory bowel diseases [J]. J Crohns Colitis, 2016, 10(2): 226-235.
|
| [5] |
Mutalib M. Renal involvement in paediatric inflammatory bowel disease [J]. Pediatr Nephrol, 2021, 36(2): 279-285.
|
| [6] |
Angeletti A, Arrigo S, Madeo A, et al. Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature [J]. BMC Nephrol, 2021, 22(1): 146.
|
| [7] |
Gisbert JP, González-Lama Y, Maté J. 5-aminosalicylates and renal function in inflammatory bowel disease: a systematic review [J]. Inflamm Bowel Dis, 2007, 13(5): 629-638.
|
| [8] |
Yoo YJ, Chung SY, Gu DH, et al. A case of late onset-acute tubulointerstitial nephritis with infliximab and mesalazine treatment in a patient with Crohn′s disease [J]. Korean J Gastroenterol, 2014, 63(5): 308-312.
|
| [9] |
McConnell N, Campbell S, Gillanders I, et al. Risk factors for developing renal stones in inflammatory bowel disease [J]. BJU Int, 2002, 89(9): 835-841.
|
| [10] |
Parks JH, Worcester EM, O′Connor RC, et al. Urine stone risk factors in nephrolithiasis patients with and without bowel disease [J]. Kidney Int, 2003, 63(1): 255-265.
|
| [11] |
Kane S. Urogenital complications of Crohn′s disease [J]. Am J Gastroenterol, 2006, 101(12 Suppl): S640-S643.
|
| [12] |
Kim YN, Jung Y. Renal and urinary manifestations of inflammatory bowel disease [J]. Korean J Gastroenterol, 2019, 73(5): 260-268.
|